Join this live event: Unlocking the Full Potential of AAV-Mediated Gene Delivery

Adeno-associated virus (AAV) vectors continue to be at the forefront of gene therapy innovation. Yet, despite significant advances, challenges remain in optimizing AAV-based treatments for broader clinical application.

In this Cell & Gene Live hosted by Cell & Gene's Chief Editor, Erin Harris, we are honored to host two leading experts in the field:

These pioneering companies share a rich history in AAV gene therapy with roots tracing back to the groundbreaking work of Dr. James Wilson. Browne and Hunter will discuss the latest developments in AAV vector design, manufacturing processes, and clinical strategies. They will also address key issues such as immunogenicity and regulatory considerations that are shaping the future of AAV gene therapies.